RIBAVIRIN (RIBAVIRIN) — FDA Approval ANDA202546 (BEXIMCO PHARMS USA)
RIBAVIRIN (RIBAVIRIN) — FDA Approval ANDA202546 (BEXIMCO PHARMS USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RIBAVIRIN; Active ingredients: RIBAVIRIN; Application number: ANDA202546.
| Brand name | RIBAVIRIN |
|---|---|
| Active ingredients | RIBAVIRIN |
| Application number | ANDA202546 |
| Sponsor | BEXIMCO PHARMS USA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 4 |
| First approval date | 20140812 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →